Report Company Directory

China Resources Pharmaceutical Group Ltd.

• A double requalification allows CHINA RESOURCES PHARMACEUTICAL GROUP to improve to Slightly Positive by TheScreener
• Morningstar | CR Pharma's Full-Year Results in Line, but Less Impressive Than 1H; Debt Levels Rise. See Updated Analyst Note from 22 Mar 2019 by Morningstar
• CR Pharma's Full-Year Results in Line, but Less Impressive Than 1H; Debt Levels Rise by Morningstar
• CR Pharma Is a Well-Branded Pharmaceutical Conglomerate in China by Morningstar
• Morningstar | CR Pharma's Full-Year Results in Line, but Less Impressive Than 1H; Debt Levels Rise by Morningstar
• Morningstar | China to audit 77 drugmakers, government likely to speed up pricing reform by Morningstar
• China to audit 77 drugmakers, government likely to speed up pricing reform by Morningstar
• China Resources Pharmaceutical Group Limited: 1 director maiden bought by SmartInsider
• Morningstar | Fudan Zhangjiang Applies for Listing in China; Chinese Healthcare Stocks Rally by Morningstar
• Fudan Zhangjiang Applies for Listing in China; Chinese Healthcare Stocks Rally by Morningstar

China Resources Power Holdings Co. Ltd.

• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research
• China Resources Power Holdings Company Limited by CFRA Research

China Resources Sanjiu Medical & Pharmaceutical Co. Ltd. Class A

• 快评: 华润三九 "Q325业绩仍承压" (买入) 朱 by UBS AG
• First Read: Sanjiu Medical & Ph "Q325 results still under pressure" (Buy) Zhu by UBS AG
• China TCM Monthly Tracker "TCM raw material prices in 9M25 down 14% YoY;..." by UBS AG
• Global Equity Strategy "2026 Outlook part 2: Style, Themes & Sectors" Garthwaite by UBS AG
• 中国中药行业月度追踪 "25年1-11月中药材价格同比下降15%；11月环比下降6%" 刘 by UBS AG
• China TCM Monthly Tracker "TCM raw material prices in 11M25 down 15% YoY;..." by UBS AG
• Global Equity Strategy "Overweight healthcare equipment; benchmark pharma"... by UBS AG
• Q-Series "Silver hair, golden returns? Navigating China’s healthcare boom" Chen by UBS AG
• 中国中药行业月度追踪 "25年1-8月中药材价格同比下降14%；8月环比下降2%" 朱 by UBS AG
• China TCM Monthly Tracker "TCM raw material prices in 8M25 down 14% YoY;..." by UBS AG

CHINA RISUN GRP LTD

China Rongzhong Financial Holdings (P Chip)

• China Rongzhong Financial Holdings Company Limited: 1 director by SmartInsider
• Ford Equity International Rating and Forecast Report by Ford Equity Research